1. Home
  2. AZIO vs ALLR Comparison

AZIO vs ALLR Comparison

Compare AZIO & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AZIO

Azio AI Holdings Inc. Common Stock

N/A

Current Price

$1.58

Market Cap

26.0M

ML Signal

N/A

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.40

Market Cap

25.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZIO
ALLR
Founded
N/A
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
25.6M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
AZIO
ALLR
Price
$1.58
$1.40
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.75
AVG Volume (30 Days)
268.6K
64.7K
Earning Date
N/A
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,939,008.00
$320,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
217.58
N/A
52 Week Low
$1.23
$0.77
52 Week High
$1.84
$2.35

Technical Indicators

Market Signals
Indicator
AZIO
ALLR
Relative Strength Index (RSI) 45.14 58.76
Support Level $1.32 $1.34
Resistance Level $1.76 $1.42
Average True Range (ATR) 0.20 0.08
MACD 0.01 0.02
Stochastic Oscillator 62.23 60.12

Price Performance

Historical Comparison
AZIO
ALLR

About AZIO Azio AI Holdings Inc. Common Stock

Azio AI Holdings Inc is a technology infrastructure company focused on developing, owning, and operating artificial intelligence data centers, enterprise GPU compute infrastructure, digital power solutions, and digital asset mining operations. The company operates an integrated AI infrastructure business encompassing AI data center development, the sale and distribution of enterprise GPU systems and server infrastructure, high-performance computing solutions, power hosting, and strategic technology investments, serving enterprise and institutional customers across domestic and international markets.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

Share on Social Networks: